77 related articles for article (PubMed ID: 6526080)
1. [Further observations of the inhibitory effect of the disodium salt of 9-hydroxy-8,12-trans-19,20-bis-norprostanoic acid (rosaprostol) on gastric secretion].
Adami M; Scarpignato C; Signorini G; Coruzzi G; Bertaccini G
Farmaco Prat; 1984 Nov; 39(11):409-16. PubMed ID: 6526080
[No Abstract] [Full Text] [Related]
2. Nonprotein sulfhydryls as possible components of the protective effect of rosaprostol on the rat gastric mucosa.
Fumagalli R; Caponi R; Corsini A; Brambilla A; Palmira M; Bernini F; Valcavi U
Prostaglandins; 1985 Mar; 29(3):467-74. PubMed ID: 3858913
[TBL] [Abstract][Full Text] [Related]
3. The effects of 9-hydroxy-19,20-bis-norprostanoic acid on mucus, acid and gastrin secretion in duodenal ulcer patients.
Foschi D; Ferrante F; Callioni F; Bastagli A; Rovati V
Prostaglandins Leukot Med; 1984 Aug; 15(2):147-52. PubMed ID: 6593741
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin cytoprotection in man: effectiveness of rosaprostol.
Foschi D; Trabucchi E; Galeone M; Ferrante F; Toti GL; Castoldi L; Musazzi M; Centemero A; Montorsi W
Int J Tissue React; 1988; 10(1):53-7. PubMed ID: 3397253
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometric identification of urinary and plasma metabolites of 9-hydroxy-19,20-bis-nor-prostanoic acid (rosaprostol).
Benfenati E; Fanelli R; Chiabrando C; Valcavi U; Bosone E; Farina P
Prostaglandins; 1988 May; 35(5):665-84. PubMed ID: 3399677
[TBL] [Abstract][Full Text] [Related]
6. Gastric antisecretory, antiulcer and cytoprotective properties of 9-hydroxy-19,20-bis-nor-prostanoic acid in experimental animals.
Valcavi U; Caponi R; Brambilla A; Palmira M; Minoja F; Bernini F; Musanti R; Fumagalli R
Arzneimittelforschung; 1982; 32(6):657-63. PubMed ID: 7202371
[TBL] [Abstract][Full Text] [Related]
7. Cytoprotection by 9-hydroxy-19,20-bis-nor-prostanoic acid in humans: an endoscopic and histologic study.
Trabucchi E; Foschi D; Baratti C; Colombo R; Toti GL; Castoldi L; Ferla GF; Montorsi W
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():307-10. PubMed ID: 2959069
[No Abstract] [Full Text] [Related]
8. Effects of a synthetic prostanoid, rosaprostol, on the changes of gastric acidity and digestive disorders induced by NSAID.
Di Murro R; Camarri E; Ciani D; Mariotti L; Nencioni C; Romagnoli AM
Int J Clin Pharmacol Res; 1988; 8(5):345-51. PubMed ID: 3068160
[TBL] [Abstract][Full Text] [Related]
9. Serum and urine kinetics of rosaprostol in volunteers.
Segre G; Fiaschi AI; Bianchi E; Ciani D; Tedeschi S
Arzneimittelforschung; 1988 Dec; 38(12):1846-9. PubMed ID: 3245860
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of some derivatives of 19,20-di-norprostanoic acid.
Valcavi U; Innocenti S; Zabban GB; Pezzini C
Farmaco Sci; 1975 Jul; 30(7):527-35. PubMed ID: 1149880
[No Abstract] [Full Text] [Related]
11. Synthesis and platelet aggregation inhibitory activity of 10-oxa and 10-thia prostanoic acid derivatives.
Das J; Vu T
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():788-93. PubMed ID: 2960192
[No Abstract] [Full Text] [Related]
12. Anti-aggregatory prostanoids. Part II.
Korbut R; Gryglewski RJ
Acta Physiol Pol; 1985; 36(5-6):303-16. PubMed ID: 3915632
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane A2 receptor antagonism selectively reverses platelet aggregation.
Le Breton GC; Venton DL
Adv Prostaglandin Thromboxane Res; 1980; 6():497-503. PubMed ID: 7386283
[No Abstract] [Full Text] [Related]
14. Anti-aggregatory prostanoids. Part I.
Korbut R; Gryglewski RJ
Acta Physiol Pol; 1985; 36(5-6):293-302. PubMed ID: 3915631
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of (+/-) 8,12-trans-delta5-en-cis-9-keto-13,14-en-trans-15-R,S-hydroxyprostanoic acid methyl ester.
Traverso G; Pirillo D; Damonti E; Rescia G
Farmaco Sci; 1978 Jul; 33(7):562-4. PubMed ID: 744254
[TBL] [Abstract][Full Text] [Related]
16. [Effect of 7-aza- and 13-aza-prostanoids on platelet aggregation].
Kuz'mitskiĭ BB; Malaeva LP; Khlevnikova TS; Lakhvich FA
Farmakol Toksikol; 1989; 52(4):45-8. PubMed ID: 2806527
[TBL] [Abstract][Full Text] [Related]
17. [Radioimmunoassay levels of plasma 17-estradiol, progesterone and testosterone in the preovulatory phase under basal conditions and after treatment with prostaglandin analogs].
Melloni GF; Scarazatti E; Melloni R
Boll Soc Ital Biol Sper; 1986 Aug; 62(8):939-45. PubMed ID: 3790339
[No Abstract] [Full Text] [Related]
18. [Cytoprotective effect of rosaprostol during treatment with non-steroidal anti-inflammatory agents in arthrorheumatic pathologies].
Cataldo MG; Sallì L; Scalici G; D'Aiuto A; Bongiorno A; Salerno L
Minerva Dietol Gastroenterol; 1989; 35(3):191-4. PubMed ID: 2601868
[TBL] [Abstract][Full Text] [Related]
19. [Radioimmunoassay determination of LH, FSH, prolactin, TSH and ACTH in the preovulatory phase under basal conditions and after treatment with a prostaglandin analog].
Melloni GF; Scarazatti E; Melloni R
Boll Soc Ital Biol Sper; 1986 Aug; 62(8):947-53. PubMed ID: 3024682
[No Abstract] [Full Text] [Related]
20. Inhibition of ovine gastric acid secretion by intraduodenal long-chain fatty acids.
McLeay LM; Fitzgerald JM
Am J Physiol; 1982 Aug; 243(2):G127-33. PubMed ID: 7114221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
